Form 4: Cardinal Health Director Granted Restricted Stock Units

Cardinal Health Inc. Director Robert W. Musslewhite was granted 1,067 restricted share units, vesting in November 2026.

Summary

• Robert W. Musslewhite, a Director of Cardinal Health Inc. (CAH), was granted 1,067 common shares in the form of restricted share units.
• The transaction date for this grant is November 5, 2025.
• These restricted share units were acquired at a price of $0, indicating they are part of compensation.
• Following this transaction, Mr. Musslewhite beneficially owns a total of 2,116 common shares directly.
• The restricted share units are scheduled to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.
• A Limited Power of Attorney was executed on May 5, 2025, authorizing specific individuals to file SEC reports on behalf of Mr. Musslewhite.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. It's a routine compensation disclosure, which is generally a positive for aligning director interests, but doesn't indicate new operational or financial performance.

Positives

• The grant of restricted share units aligns the director's interests with long-term shareholder value.
• The vesting schedule encourages continued service and performance.

Future Outlook

The vesting schedule for the restricted share units indicates a future commitment of the director to the company's long-term performance, with vesting tied to November 2026 or the 2026 Annual Meeting of Shareholders.

Industry Context

This grant of restricted stock units is a common practice in corporate compensation for directors, aligning their incentives with shareholder interests over a multi-year period. It reflects standard governance practices for publicly traded healthcare services and products companies like Cardinal Health.

Comparison to Industry Standards

• The grant of restricted share units to a director at a $0 price is a standard form of equity compensation in the U.S. public company landscape, comparable to practices at peers in the healthcare distribution sector such as McKesson Corporation (MCK) or AmerisourceBergen Corporation (ABC).
• The vesting schedule, typically 1-3 years for director grants, is also within industry norms, encouraging long-term commitment.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant of restricted share units aligns the director's long-term interests with shareholder value.
• Management: Streamlines SEC reporting for the director.

Next Steps

• The restricted share units are expected to vest on November 5, 2026, or earlier if the 2026 Annual Meeting of Shareholders occurs before that date.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted share units to a director as part of their compensation. While such grants are positive for aligning management and director interests with long-term shareholder value, they do not typically signal new operational performance, strategic shifts, or material financial developments that would warrant a change in investment recommendation. The transaction is expected and reflects standard corporate governance practices.

Keywords

Cardinal Health, CAH, Robert W. Musslewhite, Director, Restricted Stock Units, RSU, Insider Trading, Form 4, Equity Grant, Compensation